Back to search

Oval Medical Technologies Limited

06810585

active
ltd
england wales
Companies House
Health Score
68 / 100

Some Concerns

30/30
Filing
0/30
Financial
38/40
Risk
  • Negative net worth (-10)
  • Going concern doubt noted in accounts (-10)
  • 1 outstanding charge (-2)

Details

50/60 Station Road, Cambridge, CB1 2JH
Incorporated 05/02/2009

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 05/02/2026

Due 19/02/2027

On track

Industry

72200
Research and experimental development on social sciences and humanities

Officers

Michael John Schick

director · Since 10/12/2016

DIRECTOR

AMERICAN · UNITED STATES

Also on 1 other board

Mr Chetan Narendra Patel

director · Since 10/12/2016

DIRECTOR

AMERICAN · UNITED STATES

Also on 1 other board

Hs Secretarial Limited

secretary · Since 10/12/2016

BRITISH

Also on 112 other boards

Hs Secretarial Limited

corporate secretary · Since 10/12/2016

Reg: 04069036

Also on 112 other boards

Chetan Narendra Patel

director · Since 10/12/2016

American · United States

Michael John Schick

director · Since 10/12/2016

American · United States

Former

Gill Dickinson

secretary · Resigned 24/11/2010

Catherine Susan Minshull-Beech

director · Resigned 30/04/2013

Olivier Pierre Marcel Fourment

director · Resigned 30/09/2013

Peter Stephen Keen

director · Resigned 16/10/2013

Stevenson Alan Peter Dawson

director · Resigned 28/02/2015

Jeremy John Turner

director · Resigned 28/02/2015

Philip Liam O'Donovan

director · Resigned 10/12/2016

Thomas Cochrane Mcguire

secretary · Resigned 10/12/2016

Michael John Dey

director · Resigned 10/12/2016

Salim Haffar

director · Resigned 10/12/2016

Paul Harper

director · Resigned 10/12/2016

Lcif Representatives Limited

corporate director · Resigned 10/12/2016

James Simon Millen

director · Resigned 10/12/2016

Matthew Young

director · Resigned 23/01/2023

Barbara Ann Lead

director · Resigned 23/01/2023

Jawad Gandour Nunes

director · Resigned 14/06/2023

Elizabeth Anne Jones

director · Resigned 25/04/2025

Persons with Significant Control

Smc Pharma Services Ltd

75–100% shares
75–100% votes

Reg: 10446752 · Companies House England · Private Limited Company

Notified 10/12/2016

Charges1 outstanding

Charge
outstanding

BARCLAYS SECURITY TRUSTEE LIMITED

Created 29/04/2021Registered 05/05/2021

Change History

status → active
2026-07-15

Active

type → ltd
2026-07-15

Private Limited Company

address line1 → 50/60 Station Road
2026-07-15

50/60 STATION ROAD

post town → Cambridge
2026-07-15

CAMBRIDGE

CompanyRankvs 496+ SIC 72200 peers
45

Financial strength1th percentile among SIC peers · 0/25
Employees97th percentile among SIC peers · 15/15
LiquidityCurrent ratio 2.21× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006 . The following principal accounting policies have been applied: 2.2 Going concern The Company’s ability to continue trading relies on the continued financial support from its parent company, SMC Pharma Services Ltd (formerly Cambridge Pharma Services Ltd). At the balance shee

Key FinancialsYear ending 31/12/2025

Net Worth

-£3.4M

Balance sheet strength

Cash

£50k

Cash in the bank

Net Current Assets

£2.0M

Working capital

Current Assets

£3.6M

Current Liabilities

£1.6M

Fixed Assets

£1.2M

Debtors

£3.5M

8avg. employees-13

Balance Sheet

Assets less current liabilities£3.2M
Prepared with Caseware UK (AP4) 2025.0.111

EstimatesDerived

YearCurrent RatioImplied Profit
20252.21-£3.0M
20231.19—

Derived from filed accounts. Not audited figures.